Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…
Science experiments go bush
By Richard Schoonraad | BioDiscovery, Community, Media Releases, News & EventsJigalong Remote Community School students, living on the edge of the Great Sandy Desert on the western side of the Rabbit Proof Fence, were last week introduced to the world…
Over 1100 Walkers raise $1.5M for Women’s Cancer
By Richard Schoonraad | Community, Events, News & Events, Walk for Women's Cancer10th anniversary Walk for Women’s Cancer kicks off in Perth A record 1153 walkers hit Perth streets this morning on the 10th annual New Town Toyota Walk for Women’s Cancer.…
Under the Tuscan Sun for cancer research
By Richard Schoonraad | Community, Events, News & Events, Walk for Women's CancerTuscan trek for Perth cancer researchers On the steep cobbled streets of medieval towns, past vineyards and over Tuscan hillsides, Anita Tancevski-Simpson will take a moment to acknowledge people who…
When Nicole Kruse was diagnosed with breast cancer in late 2016, she made it her mission to get well enough to complete a 100km running event. The massive challenge is…
Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…
Perth MedTech firm secures funding for cannula innovation
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & EventsVeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…
$5m funding awarded to researchers for inherited disease hunt
By Richard Schoonraad | Funding, Genes, Genetic Disease, Genetic Disease, Genetics, Media Releases, News & Events, Other Genetic Disorders, ResearchNational approach to finding the causes of several debilitating diseases Medical Research Future Fund awards $4,877,532 over 5 years to ‘The missing heritability of human disease: discovery to implementation’. Blood…